AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Patients With Advanced Solid Tumors

A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation NCT06908434Phase 11 site๐Ÿ“ Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci128 tablets A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors NCT05866692Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Jinan TYK Medicines, Inc ยท Tests: TY-2699a TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors NCT05142423Phase 1, Phase 21 site๐Ÿ“ Hangzhou Akeso ยท Tests: AK109+AK104 A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib DXP-106 in Solid Tumor Patients. NCT07532018Phase 14 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai๐Ÿ“ Taiyuan Singlomics Biopharmaceuticals Zhuhai Co., Ltd. ยท Tests: DXP-106 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites๐Ÿ“ Atlanta๐Ÿ“ Nashville๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: GVV858, Fulvestrant, Letrozole A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours NCT06682780Phase 1, Phase 21 site๐Ÿ“ Shanghai LaNova Medicines Limited ยท Tests: LM-2417, Docetaxel, Toripalimab/Tirelizumab, Carboplatin, Niraparib A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors NCT07250386Phase 11 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: CEA-targeted CAR-T (Intravenous), CEA-targeted CAR-T (Intrapleural) Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors NCT00870129NA1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: MRI and advanced MRI sequences A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib AB122 Platform Study NCT04999761Phase 19 sites๐Ÿ“ Aichi๐Ÿ“ Chiba๐Ÿ“ Ehime Taiho Pharmaceutical Co., Ltd. ยท Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors NCT06947291Phase 21 site๐Ÿ“ Hangzhou CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ยท Tests: Glumetinib Tablets, Docetaxel for Injection (Albumin-bound) A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors NCT07469982Phase 11 site๐Ÿ“ Shanghai Shouyao Holdings (Beijing) Co. LTD ยท Tests: SY-9453 Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment NCT07036133Phase 14 sites๐Ÿ“ Cerritos๐Ÿ“ Chicago๐Ÿ“ Detroit Acrotech Biopharma Inc. ยท Tests: Pralatrexate Injection A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors NCT07110883Phase 12 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai CSPC Megalith Biopharmaceutical Co.,Ltd. ยท Tests: SYS6023 PM534 Administered Intravenously to Patients With Advanced Solid Tumors NCT05835609Phase 13 sites๐Ÿ“ Barcelona๐Ÿ“ Madrid๐Ÿ“ Madrid PharmaMar ยท Tests: PM534 A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors NCT06907628Phase 11 site๐Ÿ“ Jinan Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-3792 Injection A Phase โ…  Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors NCT07229898Phase 14 sites๐Ÿ“ Harbin๐Ÿ“ Jinan๐Ÿ“ Shanghai Henan Genuine Biotech Co., Ltd. ยท Tests: GEN-725 tablets Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001 NCT06410092Phase 13 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Chengdu Sound Biopharmaceuticals Ltd. ยท Tests: FTL001 XTX301 in Patients With Advanced Solid Tumors NCT05684965Phase 1, Phase 212 sites๐Ÿ“ Sacramento๐Ÿ“ New Haven๐Ÿ“ Saint Louis Park Xilio Development, Inc. ยท Tests: XTX301 Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors NCT05631964Phase 11 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M07D1 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 ORB-021 In Patients With Advanced Solid Tumors NCT06607939Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Houston Orionis Biosciences Inc ยท Tests: ORB-021 A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour NCT06383871Phase 11 site๐Ÿ“ Tianjin Shandong Suncadia Medicine Co., Ltd. ยท Tests: HRS-7058 capsule/ HRS-7058 tablet TR64 in Patients With Advanced Solid Tumors NCT05649345Phase 12 sites๐Ÿ“ Bengbu๐Ÿ“ Shenyang Tarapeutics Science Inc. ยท Tests: TR64 Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia. NCT07577206EARLY Phase 11 site๐Ÿ“ Naples National Cancer Institute, Naples ยท Tests: [68Ga]Ga-R54 PET/CT Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors NCT07415863Phase 1, Phase 21 site๐Ÿ“ Beijing CSPC Megalith Biopharmaceutical Co.,Ltd. ยท Tests: SYS6043 A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ St Louis Angiex, Inc. ยท Tests: AGX101
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy